MCRB financials
Seres Therapeutics (MCRB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- MCRB revenue was $789.00K in fiscal 2025, net income $5.70M.
MCRB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $789.00K | – | -$93.97M | $5.70M | 0.64 |
| 2024 | $0.00 | – | -$121.31M | $136.00K | 0.00 |
| 2023 | $0.00 | – | -$195.10M | -$113.72M | -17.77 |
| 2022 | $7.13M | – | -$179.91M | -$250.16M | -46.20 |
| 2021 | $144.93M | – | -$64.49M | -$65.58M | -14.40 |
| 2020 | $33.22M | – | -$88.13M | -$89.13M | -22.40 |